China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, and hospital management and consulting services in the People’s Republic of China. More Details
Excellent balance sheet and fair value.
Share Price & News
How has China Resources Medical Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1515 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 1515's weekly volatility (8%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: 1515 exceeded the Hong Kong Healthcare industry which returned 28.5% over the past year.
Return vs Market: 1515 exceeded the Hong Kong Market which returned 28.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is China Resources Medical Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StDeclining Stock and Decent Financials: Is The Market Wrong About China Resources Medical Holdings Company Limited (HKG:1515)?
3 weeks ago | Simply Wall StWe Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt
1 month ago | Simply Wall StShould You Be Impressed By China Resources Medical Holdings' (HKG:1515) Returns on Capital?
Is China Resources Medical Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 1515 (HK$6.23) is trading below our estimate of fair value (HK$9.76)
Significantly Below Fair Value: 1515 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 1515 is poor value based on its PE Ratio (21.2x) compared to the HK Healthcare industry average (20.7x).
PE vs Market: 1515 is poor value based on its PE Ratio (21.2x) compared to the Hong Kong market (11.8x).
Price to Earnings Growth Ratio
PEG Ratio: 1515 is poor value based on its PEG Ratio (1.2x)
Price to Book Ratio
PB vs Industry: 1515 is good value based on its PB Ratio (1.1x) compared to the HK Healthcare industry average (1.3x).
How is China Resources Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1515's forecast earnings growth (17.1% per year) is above the savings rate (1.5%).
Earnings vs Market: 1515's earnings (17.1% per year) are forecast to grow slower than the Hong Kong market (18.3% per year).
High Growth Earnings: 1515's earnings are forecast to grow, but not significantly.
Revenue vs Market: 1515's revenue (8.1% per year) is forecast to grow slower than the Hong Kong market (13.3% per year).
High Growth Revenue: 1515's revenue (8.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1515's Return on Equity is forecast to be low in 3 years time (6.6%).
How has China Resources Medical Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1515 has high quality earnings.
Growing Profit Margin: 1515's current net profit margins (11.3%) are lower than last year (18.5%).
Past Earnings Growth Analysis
Earnings Trend: 1515's earnings have grown significantly by 41.5% per year over the past 5 years.
Accelerating Growth: 1515's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1515 had negative earnings growth (-20.6%) over the past year, making it difficult to compare to the Healthcare industry average (1%).
Return on Equity
High ROE: 1515's Return on Equity (5.1%) is considered low.
How is China Resources Medical Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 1515's short term assets (CN¥4.1B) exceed its short term liabilities (CN¥2.2B).
Long Term Liabilities: 1515's short term assets (CN¥4.1B) exceed its long term liabilities (CN¥415.6M).
Debt to Equity History and Analysis
Debt Level: 1515's debt to equity ratio (14.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 1515's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 1515's debt is well covered by operating cash flow (64.8%).
Interest Coverage: 1515 earns more interest than it pays, so coverage of interest payments is not a concern.
What is China Resources Medical Holdings's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: 1515's dividend (1.42%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (1.95%).
High Dividend: 1515's dividend (1.42%) is low compared to the top 25% of dividend payers in the Hong Kong market (5.98%).
Stability and Growth of Payments
Stable Dividend: 1515 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 1515's dividend payments have increased, but the company has only paid a dividend for 7 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (30%), 1515's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: 1515 is not forecast to pay a dividend in 3 years.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Libing Cheng (56 yo)
Mr. Libing Cheng serves as Vice President of Phoenix Healthcare Group Co. Ltd. Mr. Cheng served as an Executive General Manager at Phoenix Healthcare Group Co. Ltd. since March 2013. Mr. Cheng joined Phoen...
CEO Compensation Analysis
Compensation vs Market: Libing's total compensation ($USD1.00M) is above average for companies of similar size in the Hong Kong market ($USD455.63K).
Compensation vs Earnings: Libing's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Experienced Management: 1515's management team is considered experienced (3.5 years average tenure).
Experienced Board: 1515's board of directors are considered experienced (4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
China Resources Medical Holdings Company Limited's company bio, employee growth, exchange listings and data sources
- Name: China Resources Medical Holdings Company Limited
- Ticker: 1515
- Exchange: SEHK
- Founded: 2007
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: HK$7.962b
- Shares outstanding: 1.30b
- Website: https://www.crmedical.hk
Number of Employees
- China Resources Medical Holdings Company Limited
- Kunlun Center Office Building
- 14th Floor
- Beijing Province
China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, and hospital management and consulting services in the People’s Republic of China. The company ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/19 10:09|
|End of Day Share Price||2021/04/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.